(Q52019570)

19 April 2018

title

Cardiovascular effects of fluvoxamine and maprotiline in depressed patients. (English)

1 reference

19 April 2018

1 reference

W Hewer

1

1 reference

19 April 2018

W Rost

series ordinal

2

1 reference

19 April 2018

W F Gattaz

series ordinal

3

1 reference

19 April 2018

publication date

1 January 1995

1 reference

19 April 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

19 April 2018

volume

246

1 reference

19 April 2018

page(s)

1-6

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1007/bf02191808

exact match

0 references

cites work

Mianserin, maprotiline and intracardiac conduction

1 reference

https://api.crossref.org/works/10.1007%2FBF02191808

A placebo controlled study of the cardiovascular effects of fluvoxamine and clovoxamine in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02191808

Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02191808

Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02191808

Cardiovascular effects of paroxetine

21 January 2018

1 reference

12 December 2020

Effect of fluoxetine on the electrocardiogram.

1 reference

12 December 2020

Treating the depressed patient with cardiovascular problems

1 reference

12 December 2020

Cardiovascular effects of therapeutic doses of tricyclic antidepressants: importance of blood level monitoring

1 reference

12 December 2020

Electrocardiogram changes and therapeutic desipramine and 2-hydroxy-desipramine concentrations in elderly depressives

1 reference

12 December 2020

Fluoxetine-induced bradycardia and syncope in two patients

1 reference

12 December 2020

Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients

1 reference

12 December 2020

Therapeutic drug monitoring of tricyclic antidepressants: a standard of care issue.

1 reference

12 December 2020

Electrocardiographic changes in rats during chronic treatment with antidepressant and neuroleptic drugs

1 reference

12 December 2020

Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications

1 reference

12 December 2020

Cardiovascular effects of doxepin in cardiac patients with ventricular arrhythmias

1 reference

12 December 2020

The cardiovascular effects of antidepressants.

1 reference

12 December 2020

Desipramine: cardiovascular effects and plasma levels

1 reference

12 December 2020

Death, depression, and heart disease

1 reference

12 December 2020

Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression

1 reference

12 December 2020

Cardiovascular effects and toxicity of anxiolytics and antidepressants

1 reference

12 December 2020

Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states

1 reference

12 December 2020

Effect of maprotiline on cardiac arrhythmias

1 reference

12 December 2020

Cardiovascular effects of intrathecal administration of agents active at 5-hydroxytryptamine1-receptors in the rat: modulation by substance P and a substance P antagonist

1 reference

12 December 2020

Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients

1 reference

12 December 2020

Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed

1 reference

12 December 2020

Review of the cardiovascular effects of heterocyclic antidepressants.

1 reference

12 December 2020

2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults

1 reference

12 December 2020

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

12 December 2020

Safety database on fluvoxamine: analysis and report

1 reference

12 December 2020

Incidence of Cardiac Arrhythmias During Antidepressant Therapy with Maprotiline or Nomifensine

1 reference

12 December 2020

Acute cardiac effects of fluvoxamine and other antidepressants in conscious rabbits

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02191808

1 reference

19 April 2018

PubMed ID

8773212

1 reference

19 April 2018